Cross-platform pathway-based analysis identifies markers of response to the PARP inhibitor olaparib

Anneleen Daemen, Denise M. Wolf, James E. Korkola, Obi L. Griffith, Jessica R. Frankum, Rachel Brough, Lakshmi R. Jakkula, Nicholas J. Wang, Rachael Natrajan, Jorge S. Reis-Filho, Christopher J. Lord, Alan Ashworth, Paul T. Spellman, Joe W. Gray, Laura J. Van'T Veer

Research output: Contribution to journal › Article › peer-review